Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News OmniAb Inc OABI

Healthcare Biotechnology
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company’s technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for... see more

Current News (NDAQ:OABI)

Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

Business Wire December 15, 2025

OmniAb to Hold OmniUltra Virtual Investor Event on December 15

Business Wire December 4, 2025

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

Business Wire November 17, 2025

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Business Wire November 4, 2025

OmniAb to Participate in Three Investor Conferences in November

Business Wire October 16, 2025

OmniAb to Report Third Quarter 2025 Financial Results on November 4

Business Wire October 14, 2025

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

Business Wire September 2, 2025

OmniAb Announces $30 Million Private Placement

Business Wire August 25, 2025

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

Business Wire August 6, 2025
View More News ››

Opinion & Analysis (NDAQ:OABI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:OABI)

OmniAb, Inc. (NASDAQ:OABI): Diverse Antibody Discovery Platf

http://beyondspx.com/2024/08/02/omniab-inc-nasdaqoabi-diverse-antibody-discovery-platform-driving-long-term-value/
MikeTester - August 3, 2024
View more Bullboard ››

Green Bridge Metals Corporation

Green Bridge Metals Corporation

Green Bridge Metals Corporation engages in the acquisition, exploration, and development of mining projects in Canada. The ...
View More »

Podcasts